Brighton Jones LLC’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,333
Closed -$7K 311
2017
Q4
$7K Hold
3,333
﹤0.01% 293
2017
Q3
$7K Hold
3,333
﹤0.01% 294
2017
Q2
$14K Buy
+3,333
New +$17.9K ﹤0.01% 275

Other funds holding MBVX

Brighton Jones LLC's MBVX Position: Q1 2018 in Review

Brighton Jones LLC sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q1 2018, closing a stake of 3,333 shares — an estimated $7K sold.

Brighton Jones LLC first reported a position in MBVX in Q2 2017 and held it in 3 quarters. The position peaked at $14K in Q2 2017. 11 funds tracked by Wall St. Rank hold MBVX as of Q1 2018.

  • Brighton Jones LLC reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q1 2018 after selling out during the quarter.
  • Brighton Jones LLC sold 3,333 MABVAX THERAPEUTICS HLDGS INC shares in Q1 2018, an estimated $7K.
  • Brighton Jones LLC first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q2 2017 and held it in 3 quarters.
  • Brighton Jones LLC's MABVAX THERAPEUTICS HLDGS INC position peaked at $14K in Q2 2017.
  • 11 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q1 2018.

Based on Brighton Jones LLC's 13F filing for Q1 2018, filed 3 May 2018.